Video-Supported Medication Education for Women Undergoing In Vitro Fertilization (IVF): Quality of Life and Psychosocial Effects

Not Applicable

Recruiting

• Conditions: Infertility; In Vitro Fertilization; Psychosocial Support Systems; Quality of Life; Health Education
• Interventions: Other: Education via video (QR code links)

• Registration Number: NCT06515275
• Lead Sponsor: Acibadem University

Brief Summary

Reproductive health problems, particularly infertility, affect 48 million couples globally, ranking as the fifth most serious global obstacle for women. Infertility can lead to significant psychosocial effects, including stress, anxiety, and depression, with women experiencing these impacts more severely than men. In vitro fertilization (IVF) offers a solution but comes with emotional, physical, and psychosocial challenges, particularly for women, who often experience fatigue, headaches, weight gain, and stress. Effective support mechanisms, such as information and education, are crucial in improving the IVF experience. Video-assisted educational programs have shown promise in enhancing knowledge and reducing stress during IVF treatment. However, there is a lack of studies evaluating their impact on the quality of life and psychosocial status of women undergoing IVF. This study aims to examine the effect of video-supported training on drug use, quality of life, and psychosocial status of women during IVF treatment, hypothesizing that it will improve quality of life, increase emotional capacity, and reduce anxiety.

Detailed Description

Not available

Study Timeline

• Study Start: 2024-07-11
• Study First Submitted: 2024-07-17
• Study First Submitted QC: 2024-07-17
• Study First Posted: 2024-07-23
• Status Verified: 2025-01
• Last Update Submitted: 2025-01-31
• Last Update Posted: 2025-02-04
• Primary Completion: 2025-02-11
• Study Completion: 2025-07-15

Recruitment & Eligibility

• Status: RECRUITING
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

• Being female
• Undergoing infertility treatment
• Aged 18-49 years
• Owning a tablet, smartphone, or similar device
• Having internet access
• Undergoing IVF treatment for the first time

Exclusion Criteria

• Previously received controlled ovarian stimulation treatment
• Patients undergoing frozen embryo transfer
• No internet access
• Refusal to participate in the IVF medication teaching session

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Experimental Group	Education via video (QR code links)	Participants will complete a demographic and treatment-related questionnaire. Prior to starting ovulation induction, they will complete the SCREENIVF, STAI, and FertiQol scales. On the first day of ovulation induction, participants will receive face-to-face and video-assisted education on prescribed medications, covering purpose, dose, administration, injection technique, timing, effects, and side effects. After follicle tracking confirms readiness for egg retrieval, participants will receive individual education on the ovulation-triggering medication, followed by QR code-linked educational videos specific to this medication. Post-oocyte aspiration, once sedation effects wear off, participants will complete the SCREENIVF, STAI, and FertiQol scales, along with an Education Satisfaction Evaluation Form.

Primary Outcome Measures

Name	Time	Method
State-Trait Anxiety Inventory (STAI)	to both groups before the intervention and after oocyte aspiration (OPU)	A 40-item inventory developed by Spielberger et al. (1970) and adapted to Turkish by Öner and Le Compte (1983). The inventory measures situational anxiety (20 items) and trait anxiety (20 items).
Introductory Information Form	to both groups before the intervention	A 28-question form designed by researchers to gather sociodemographic, general health, obstetric, and gynecological history of the participants.
Screening Tool on Distress in Fertility Treatment's (SCREENIVF)	to both groups before the intervention and after oocyte aspiration (OPU)	A tool recommended by ESHRE to assess psychosocial risk factors in individuals undergoing infertility treatment. The Turkish version consists of 28 items measuring anxiety, social support, helplessness, acceptance, and depression.
Education Satisfaction Evaluation Form	to both groups after oocyte aspiration (OPU)	A form developed by researchers to assess satisfaction with medication education. It uses a 0-10 scale, with higher scores indicating greater satisfaction. The form for the experimental group will also record video viewing behavior.
Fertility quality of life tool (FertiQoL)	to both groups before the intervention and after oocyte aspiration (OPU)	A 36-item scale developed by Boivin et al. (2011) to assess the quality of life in individuals with fertility problems. The Turkish version was validated by Dural et al. (2016).

Trial Locations

Locations (1)

Merve Coşkun; 🇹🇷 Ataşehir, İstanbul, Turkey